Amgen shares pop 12% after excitement from obesity drug candidate | Pacific Coast Business Times : vimarsana.com

Amgen's new research and development facility in San Francisco. (courtesy photo) Shares of Thousand Oaks-based Amgen gained 12% on May 3, one day after the company disclosed its earnings for the first quarter of 2024 and highlighted the excitement around its weight-loss drug. During the company’s earnings call, Amgen CEO Bob Bradway commented on their

Related Keywords

San Francisco , California , United States , Bob Bradway , James Bradner , William Blair , Morgan Stanley , Amgen , Jorge Mercado Monday , Thousand Oaks Based Amgen , Chief Scientific Officer James Bradner , Horizon Therapeutics , Zacks Consensus , Central Coast , Earnings , Latest News , Subscriber Content , Technology , Top Stories , Top Story , Tri County Economy , Tri County Public Companies ,